Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Birmingham Featured PhD Programmes
University College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Kent Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
"personalised"×
10 miles

personalised PhD Projects, Programs & Scholarships

We have 78 personalised PhD Projects, Programs & Scholarships

  • "personalised" ×
  • clear all
Order by 
Showing 1 to 10 of 78
  Stroke risk in a “healthy” patient: personalised modelling of thrombus formation and movement in the blood stream after catheter ablation therapy for atrial fibrillation
  Dr A de Vecchi, Dr O Aslanidi
Applications accepted all year round
Stroke is a common complication of atrial fibrillation (AF), which itself is the most widespread cardiac arrhythmia. However, the assessment of stroke risk is not straightforward in a large population of AF patients who are presented in sinus rhythm (SR), including patients after catheter ablation (CA) therapy, i.e.
  Stroke risk in a “healthy” patient: personalised modelling of thrombus formation and movement in the blood stream after catheter ablation therapy for atrial fibrillation
  Dr A De Vecchi
Applications accepted all year round
1st Supervisor - Dr Adelaide De Vecchi. 2nd Supervisor - Dr Oleg Aslanidi. Stroke is a common complication of atrial fibrillation (AF), which itself is the most widespread cardiac arrhythmia.
  MRC Precision Medicine DTP: Developing Personalised Precision Medical Approaches for Paediatric Intensive Care
  Dr T Lo, Dr L Moss, Dr J Escudero Rodriguez
Application Deadline: 7 January 2019
Title - Developing Personalised Precision Medical Approaches for Paediatric Intensive Care through Data Informatics Research on the Impact of Acute Clinical and Physiological Phenotypes on Outcome and Health Economics.
  MRC DiMeN Doctoral Training Partnership: Personalised mitochondrial health: a functional and multi-omic assessment to predict individual susceptibility to hepatotoxicity of antiepileptic drugs
  Dr A Chadwick, Dr A Alfirevic, Dr R Jenkins
Application Deadline: 21 January 2019
Background. The realisation that mitochondrial genetics are an important, and under-researched, factor in personalised medicine is growing.
  Designing Technology for Personalised Nutrition
  Dr F Hwang
Applications accepted all year round
This PhD investigates the design of technology to provide personalised nutrition advice. Non-communicable diseases such as diabetes and cardiovascular disease are major challenges globally, and can be addressed, in part, by eating a healthier diet.
  Personalised rehabilitation for musculoskeletal and spinal pain
  Dr A Rushton, Prof D Falla, Dr N Heneghan
Applications accepted all year round
Our PhD students are an active part of our Centre of Precision Rehabilitation for Spinal Pain (CPR Spine). CPR Spine was established at the University of Birmingham in 2016 following a ~£1M investment awarded to Professor Falla and Dr Rushton.
  Cytochromes P450 in Cancer: Opportunities for Development of Personalised Medicine - Project 1
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof P Loadman
Applications accepted all year round
The improved understanding of cancer biology provides opportunities for the development of molecular targeted therapies.
  Cytochromes P450 in Cancer: Opportunities for Development of Personalised Medicine - Project 2
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof P Loadman
Applications accepted all year round
The improved understanding of cancer biology provides opportunities for the development of molecular targeted therapies.
  Machine Learning and Integrative Approaches in Immunology: Developing machine-learning and mathematical models to understand heterogeneity of response to personalised cancer immunotherapy
  Dr H Koohy, Prof V Cerundolo, Prof T Dong, Prof A Simmons
Application Deadline: 11 January 2019
Cancer immunology is an area of cancer research that is gaining tremendous momentum. However, responses to immunotherapy are heterogeneous and patient care could be substantially improved by better understanding of how and why responses to immunotherapeutic approaches vary in different patients.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.